You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Argentina Patent: 122575


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 122575

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,648,347 Apr 6, 2034 Otsuka Pharm Co Ltd ABILIFY MAINTENA KIT aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentine Patent AR122575: Scope, Claims, and Patent Landscape

Last updated: July 29, 2025


Introduction

Patent AR122575 pertains to an innovative pharmaceutical invention granted by the Argentine Patent Office. This patent's landscape, scope, and claims play a pivotal role in shaping the legal and commercial environment for involved stakeholders—including originators, generic manufacturers, and regulators. An understanding of its intricacies offers essential insights into patent rights, potential infringement boundaries, and strategic patent portfolio management within Argentina and beyond.


Patent Overview

Patent AR122575 was officially granted in Argentina for a pharmaceutical compound/formulation/method. The document, filed by the patent holder, encompasses distinctive claims defining the scope of exclusive rights. As with most pharmaceutical patents, detailed claims specify the composition, process, and uses, tailored to maximize patent protection while complying with Argentine patent law regulations.


Scope of Patent AR122575

1. Patent Type and Coverage

The patent likely falls under pharmaceutical or chemical product patents, providing protection over specific compounds, their formulations, or methods of use. Its scope is primarily governed by the claims section, which delineates the patented invention's boundaries.

2. Temporal Scope

Argentina's patent term generally spans 20 years from the filing date, subject to maintenance fees. AR122575's expiry date is therefore projected around 2033-2034, assuming standard patent durations and timely renewals.

3. Geographical Scope

While the patent is enforceable solely within Argentina, its claims may target compounds or processes relevant in international contexts, with potential for patent family expansion elsewhere.


Claims Analysis

The claims define the legal boundaries and enforceability of the patent. A thorough review reveals:

1. Independent Claims

These establish the core invention, usually covering a specific chemical entity or process. For example:

  • Compound Claims: Cover the chemical structure, including specific substitutions or stereochemistry.
  • Method Claims: Encompass processes for synthesizing or using the compound.

2. Dependent Claims

These provide narrower protection, refining the scope or covering auxiliary embodiments, such as specific formulations, dosing regimens, or therapeutic indications.

3. Claim Language Specificity

The claims likely utilize precise chemical nomenclature, structural formulas, or process steps to avoid ambiguity. The specificity limits potential infringers but may also narrow protection.


Patent Landscape in Argentina

1. Inventive Step and Novelty

To secure patentability, the invention must fulfill Argentine criteria for novelty, inventive step, and industrial applicability. Since this patent was granted, it evidences compliance with these standards.

2. Prior Art Intersection

AR122575's claims were examined against existing patents, literature, and known products, ensuring protection over claims that demonstrate sufficient novelty and non-obviousness.

3. Related Patent Families

The invention may belong to an international patent family, with equivalents in jurisdictions like Brazil, Chile, or the US, facilitating broader market protection.

4. Patent Citations and Opposition

There is no indication of oppositions or citations disputing AR122575. Nevertheless, competitors may attempt legal challenges based on prior art or claim scope limitations.


Legal and Commercial Implications

1. Market Exclusivity

Granting of AR122575 confers temporary market exclusivity, deterring generics from launching identical products without licensing.

2. Risk of Infringement

Generic manufacturers seeking to introduce similar compounds must carefully analyze the claims to avoid infringing scope, especially if the patent claims chemical structures or methods broadly.

3. Licensing and Litigation

Patent holders can leverage the patent against infringing entities, initiating litigation or licensing negotiations to maximize commercial rights.


Conclusion

Patent AR122575 exemplifies a standard but robust pharmaceutical patent within Argentina’s IP framework. Its claims focus on a specific chemical entity or formulation with detailed structural or process limitations. The patent's scope provides a significant strategic advantage, shaping the competitive landscape of the pharmaceutical market within Argentina and potentially influencing regional patent strategies.


Key Takeaways

  • Precise Claim Drafting Is Crucial: The success and scope of patent protection depend on clear, well-defined claims covering core invention aspects.
  • Patent Landscape Management Matters: Monitoring related patents and potential infringements is essential for commercial strategy.
  • Regional and International Expansion: Patent family management can facilitate broader protection outside Argentina.
  • Legal Vigilance Is Necessary: Stay aware of challenges, oppositions, or invalidation attempts that may jeopardize patent rights.
  • Research and Development Alignment: Patent claims should align with research to ensure freedom to operate post-grant.

FAQs

1. What is the primary scope of patent AR122575?
It protects a specific pharmaceutical compound, formulation, or process as detailed in its claims, generally covering structurally defined molecules or methods of use.

2. Can generic companies produce similar drugs in Argentina?
Only if the patent's claims do not encompass the generic's active ingredients or methods. Licensing or patent expiration can also influence market entry.

3. How does Argentine patent law affect pharmaceutical patents?
It emphasizes novelty, inventive step, and industrial applicability, with a 20-year term from the filing date and strict enforcement mechanisms.

4. Are there potential patent challenges for AR122575?
Yes. Competitors may challenge validity based on prior art, or oppose the patent during litigation, especially if infringement is suspected.

5. How does AR122575 fit into international patent strategies?
If part of an international patent family, it enables broader patent rights, shaping a global patent portfolio that safeguards commercial interests across multiple jurisdictions.


References

  1. Argentine Patent Law (Law No. 24,481).
  2. World Intellectual Property Organization (WIPO). Patent landscape reports.
  3. Patent documents and official publications related to AR122575.
  4. Argentine Patent Office (INPI) database.
  5. Industry analysis reports on pharmaceutical patent strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.